Author results

4B6L
  • Download 4b6l
  • View 4b6l
Molmil generated image of 4b6l
DISCOVERY OF ORAL POLO-LIKE KINASE (PLK) INHIBITORS WITH ENHANCED SELECTIVITY PROFILE USING RESIDUE TARGETED DRUG DESIGN
Descriptor:SERINE/THREONINE-PROTEIN KINASE PLK3, 4-[[(4R)-5-cyclopentyl-4-ethyl-3a,4-dihydro-3H-[1,2,4]triazolo[4,3-f]pteridin-7-yl]amino]-N-cyclopropyl-3-methoxy-benzamide, SULFATE ION
Authors:Brown, K., Charrier, J.D., Durrant, S., Griffiths, M., Hudson, C., Kay, D., Knegtel, R., ODonnell, M., Pierard, F., Twin, H., Weber, P., Young, S.
Deposit date:2012-08-14
Release date:2013-08-21
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Discovery of Oral Polo-Like Kinase (Plk) Inhibitors with Enhanced Selectivity Profile Using Residue Targeted Drug Design
To be Published